Measles, Mumps and Rubella (MMR) vaccine

Estimated value

goods

Awarded value

Suppliers

0

Lots

1

0 awarded

Published

22 May 2026

This is a preliminary market engagement notice

Map the supplier landscape and document your shortlist before opening the tender. The market simulation produces a defensible audit record you can attach to your procurement file.

Run market simulation

Description

Measles, Mumps and Rubella (MMR) vaccine (2027)

Scope

Reference
W211741
Commercial tool
Standalone contract
Contract dates
30 Apr 2027 to 30 Sept 2029
Main category
goods
CPV classifications
33651600

Award criteria

Criteria the buyer will use to evaluate bids.

NameDescriptionTypeWeighting
Quality criterionComparison with specificationquality
Cost criterionBenchmark pricecost
Cost criterionVaccine pricecost
Cost criterionAdditional costscost
Cost criterionAdditional savingscost
Quality criterionRisk to programme deliveryquality
Quality criterionSocial valuequality
Cost criterionStorage costscost

Participation

Conditions suppliers must meet to bid.

Covered in PSQ